Perceptive Advisors’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.26M | Sell |
|
|||||
|
2025
Q1 | $8.89M | Sell |
|
|||||
|
2024
Q4 | $28.5M | Sell |
|
|||||
|
2024
Q3 | $64M | Buy |
|
|||||
|
2024
Q2 | $21.2M | Sell |
|
|||||
|
2024
Q1 | $64M | Buy |
|
|||||
|
2023
Q4 | $37.7M | Buy |
|
|||||
|
2023
Q3 | $15.5M | Sell |
|
|||||
|
2023
Q2 | $42.3M | Buy |
|
|||||
|
2023
Q1 | $44.2M | Buy |
|
|||||
|
2022
Q4 | $35.7M | Hold |
|
|||||
|
2022
Q3 | $25M | Buy |
|
|||||
|
2022
Q2 | $11.2M | Sell |
|
|||||
|
2022
Q1 | $26.3M | Hold |
|
|||||
|
2021
Q4 | $28.1M | Buy |
|
|||||
|
2021
Q3 | $23.4M | Buy |
|
|||||
|
2021
Q2 | $14.5M | Buy |
|